Drugmaker sues competitor for alleged sham litigation

Nihal Krishan

10 August 2017

Credit: Alnylam Pharmaceuticals

Biopharmaceutical company Dicerna Pharmaceuticals has sued Alnylam Pharmaceuticals for allegedly using sham litigation and public announcements against Dicerna to illegally obtain market dominance.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Nihal Krishan

View full biography

Author

[email protected]

Tipline

Defying gravity: The Tipline for 23 September 2022
Newton’s universal law of gravitation implies that what goes up must eventually come down. While the US antitrust agencies have been quite successful in blocking companies combining horizontally, vertical movement has been another story with AT&T/Time Warner, Illumina/Grail and now UnitedHealth/Change. Speaking to GCR USA, a cohort of Department of Justice alumni try to break down where US competition enforcers might be going wrong.
All the President’s Men: The Tipline for 22 September 2022
Collecting dust: The Tipline for 21 September 2022